Core Viewpoint - Wihua New Materials (603310.SH) is acquiring a 70% stake in Jiangsu Heyutai Chemical Co., Ltd. for 154 million yuan to extend its industrial chain and enhance core competitiveness, despite Heyutai not being profitable yet [1][2]. Group 1: Acquisition Details - The acquisition will be funded through the company's own funds and bank loans, with Heyutai becoming a controlled subsidiary post-transaction [1]. - The transaction is valued at 266 million yuan, with a premium rate of 4.22% [4]. - Prior to the acquisition, Wihua New Materials provided some intermediates necessary for Heyutai's production [2]. Group 2: Financial Performance - Heyutai's projected revenues for 2024 and the first half of 2025 are 464 million yuan and 202 million yuan, respectively, with net losses of 14.12 million yuan and 4.91 million yuan [3]. - As of June 2025, Heyutai's total assets are 778 million yuan, total liabilities are 523 million yuan, and net assets are 255 million yuan [4]. - Wihua New Materials has faced performance pressures, with a 15.18% decline in revenue to 660 million yuan and a 40.96% drop in net profit to 109 million yuan in the first three quarters of 2025 [4]. Group 3: Strategic Rationale - The acquisition allows Wihua New Materials to bypass lengthy and costly pesticide product registration processes, potentially saving 2-3 years and enabling quicker market entry [2]. - Wihua aims to improve Heyutai's performance by expanding sales channels, enhancing production capacity utilization, optimizing product processes, and strengthening internal management, targeting profitability by 2026 [4].

Investment Rating - The investment rating for the company is "Buy" with a target price not specified [6] Core Views - The company's Q1 2025 performance met expectations, with revenue of 3.241 billion yuan, a year-on-year increase of 2.04%, and a net profit attributable to shareholders of 435 million yuan, a slight increase of 1.35% [1] - The industry is gradually stabilizing, and the company experienced good sales growth in Q1, particularly in its raw materials business, which was the main driver of revenue growth [1][2] - The company maintained good cost control, with a reduction in total expenses compared to the previous year, positively impacting net profit [3] - The company is advancing its projects in Liaoning, which are expected to optimize product layout and create new growth points for sustainable development [3] Financial Summary - For 2025-2027, the projected net profit attributable to the parent company is expected to be 1.47 billion yuan, 1.78 billion yuan, and 2 billion yuan respectively, reflecting a positive growth outlook [3] - The company's revenue for 2025 is estimated at 12.86 billion yuan, with a growth rate of 23.23% compared to 2024 [5] - The earnings per share (EPS) for 2025 is projected to be 3.61 yuan, with a price-to-earnings (P/E) ratio of 14.44 [5] Sales and Pricing - In Q1, the company achieved sales volumes of 28,700 tons for raw materials and 15,400 tons for formulations, representing increases of 14.8% and 2.8% year-on-year respectively [2] - The average prices for raw materials and formulations in Q1 were 63,000 yuan and 56,600 yuan, showing declines of 8.8% and 1.6% year-on-year [2] Cost Control and Project Development - The company reduced its sales expenses by approximately 1.65 million yuan year-on-year, while management and R&D expenses increased [3] - The first phase of the Liaoning project has been completed and is in the process of trial production, with several products already meeting quality standards [3]